Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

Clinical trial NCT00347412 · COMPLETED

Trial details

NCT number: NCT00347412
Sponsor: Cellectar Biosciences, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2006-11-01
Primary completion: 2010-01-01
Enrollment: 903

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.